|
|
CIRCULATING MICRORNAS AS DISEASE BIOMARKERS IN MULTIPLE SCLEROSIS |
| 3UH3TR000890-04S1 |
WEINER, HOWARD L |
NCATS |
2016 |
|
|
EVALUATION OF BIOFLUID EXRNA ISOLATION BY SMALL RNASEQ |
| 3UH3TR000890-04S2 |
GANDHI, ROOPALI |
NCATS |
2016 |
|
|
OPTIMIZATION AND NORMALIZATION STUDIES FOR INDIVIDUAL CSF SAMPLES |
| 3UH3TR000903-04S1 |
SAUGSTAD, JULIE ANNE |
NCATS |
2016 |
|
|
EXOSOME RNA-THERAPEUTICS TO PROMOTE CNS MYELINATION |
| 3UH3TR000918-04S1 |
KRAIG, RICHARD P |
NCATS |
2016 |
|
|
THE EFFICACY AND SAFETY OF A SELECTIVE ESTROGEN RECEPTOR BETA AGONIST (LY500307) |
| 3UH3TR000955-03S1 |
BREIER, ALAN |
NCATS |
2016 |
|
|
CIRCULATING MICRORNAS AS DISEASE BIOMARKERS IN MULTIPLE SCLEROSIS |
| 5UH3TR000890-04 |
WEINER, HOWARD L |
NCATS |
2016 |
|
|
CLINICAL UTILITY OF MICRORNAS AS DIAGNOSTIC BIOMARKERS OF ALZHEIMER'S DISEASE |
| 5UH3TR000903-04 |
SAUGSTAD, JULIE ANNE |
NCATS |
2016 |
|
|
EXOSOME RNA-THERAPEUTICS TO PROMOTE CNS MYELINATION |
| 5UH3TR000918-04 |
KRAIG, RICHARD P |
NCATS |
2016 |
|
|
THERAPEUTIC STRATEGY FOR LAM (LYMPHANGIOLEIOMYOMATOSIS) |
| 5UH3TR000961-03 |
EISSA, N. TONY |
NCATS |
2016 |
